Fact CheckerSign in

NCT07256015Active, not recruiting

Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy

"DEMOS" - Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy

Source: ClinicalTrials.gov · Last updated 2 Nov 2026

Brief summary (registry, in English)

The purpose of this study is to characterize the real-life experience of patients with moderate/severe psoriasis receiving deucravacitinib treatment, in terms of efficacy, safety, and health-related quality of life (HRQoL) in Italy

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
28 Aug 2025
Start date
5 Aug 2025
Primary completion date
5 Jul 2027
Lead sponsor
Bristol-Myers Squibb
Diseases
Psoriasis
NCT number
NCT07256015

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From 5 Aug 2025 to the primary completion date, 5 Jul 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Simultaneous participation in any interventional study for their moderate-to-severe psoriasis
  • Inability to participate to the study for the following reasons: patients unable to understand the aim of the study, patients unable to understand and sign the ICF

Who the study is looking for

  • Participants have initiated treatment with deucravacitinib monotherapy 4 to 8 weeks earlier according to clinical practice and to reimbursement criteria determined by National Drug Agency in Italy (AIFA)
  • Patients have moderate to severe plaque psoriasis
  • Patients have signed informed consent form (ICF)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Local Institution - 0001
Coordinator of this site? Confirm its status
VeronaItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.